Clinical Trials Browser

Phase 3 × Pseudomyxoma Peritonei × 90 days × Clear all

NCT06617897 2026-03-11

Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery

Phase 3 Recruiting

Afibrinogenemia, Blood Coagulation Disorders, Pseudomyxoma Peritonei

NCT06513065 2026-02-19

HIPEC-PMP

Phase 3 Recruiting

Pseudomyxoma Peritonei